UCA1 and ovarian carcinoma: One important finding of this work is the detection of overexpressed UCA1 in extracellular vesicles namely exosomes, which opens the possibility to use this lncRNA as a circulating biomarker for cisplatin-resistance in women with ovarian cancer [91].